Navigation Links
FASEB announces SRC: Molecular Mechanisms of Intestinal Lipid Transport & Metabolism
Date:1/22/2014

Bethesda, MD This FASEB Science Research Conference will focus on the regulation and molecular mechanisms of intestinal lipid digestion and absorption with new translational emphasis on the importance of these processes to understanding the mechanisms of health maintenance and development of chronic diseases, such as obesity, insulin resistance and diabetes, dyslipidemia, intestinal failure and gastrointestinal inflammation.

Lecture sessions will cover a broad range of topics, including lipid absorption and incretin/insulin secretion, neonatal lipid absorption, impact of the micro biome on intestinal lipid absorption, intestinal lipid transporters, role of cytoplasmic lipid droplets in lipid absorption, intestinal bile acid metabolism and chylomicron assembly and secretion. The speakers in these sessions will describe research done in an array of biological systems, from humans to rodents to neonatal swine to zebra fish to C. elegans to several in vitro model systems, and using multiple experimental approaches and new technologies.

Attendees will derive synergistic benefit from close interaction with both the speakers and the participants with diverse experimental backgrounds, which will in turn drive future advances and multidisciplinary collaborations in the field. Participants and speakers have been chosen to reflect both excellence in this health-relevant area of science, and participation by trainees and junior investigators is a major emphasis. FASEB SRC has announced a total of 36 SRCs in 2014.


'/>"/>

Contact: Robin Crawford
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB announces 2014 SRC: Protein Phosphorylation, Cellular Plasticity & Signaling Rewiring
2. FASEB announces 2014 SRC: Protein Interactions, Structures, Technologies & Networks
3. FASEB announces 2014 Science Research Conference: Biology & Pathobiology of Krueppel-Like Factors
4. FASEB announces BioArt image and video competition winners
5. MARC travel awards announced for the July 2013 FASEB Science Research Conferences
6. MARC travel awards announced for the June 2013 FASEB science research conferences
7. New FASEB analysis documents impact of budget cuts on biomedical research
8. FASEB MARC Travel Awards announced for the 2013 American College of Sports Medicine Northwest Chapter Meeting
9. FASEB joins President Obama in urging Congress to sustain investments in research and innovation
10. FASEB SRC announces conference registration open for: Melatonin Biology: Actions & Therapeutics
11. FASEB SRC announces conference: TGF-β Superfamily: Signaling in Development & Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... NEW YORK , Jan. 12, 2017  New research ... around the office of the future.  1,000 participants were simply ... last three months which we may consider standard issue.  Insights ... office of 2017 were also gathered from futurists and industry ... and Dr. James Canton .  Some ...
(Date:1/6/2017)... Calif. , Jan. 6, 2017  Privately-held ... safety studies in healthy volunteers of a novel ... to treat acute pancreatitis. Acute ... typically a mild disorder, but can be very ... failure and sepsis, where extended hospital stays, time ...
(Date:1/4/2017)... 4, 2017  CES 2017 – Valencell , ... today announced the launch of two new versions ... highly-accurate biometric sensor modules that incorporate the best ... and expertise. The two new designs include Benchmark ... hearables, and Benchmark BW2.0, a 2-LED version of ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... 19, 2017  Market Research Future has a half cooked research ... Biopsy is growing rapidly and expected to reach USD 450 Million ... ... Biopsy Market has been assessed as a swiftly growing market and ... in the coming future. There has been a tremendous growth in ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... for pharmaceutical research and development (R&D), today announced the launch of ... and interpretation for the rapidly evolving field of precision medicine. , ...
(Date:1/19/2017)... AquaBounty Technologies, Inc. (AIM: ABTU; NASDAQ: AQB), ... and a majority-owned subsidiary of Intrexon Corporation (NYSE: ... listing of its common shares on the NASDAQ Stock ... "AquaBounty,s listing on NASDAQ represents an important milestone ... the U.S. markets as we advance plans for commercial ...
(Date:1/19/2017)... ... January 19, 2017 , ... DaVita Clinical Research ... drug and device development, and Prism Clinical Research , a leader in ... Verified Clinical Trials (VCT) has been selected by both companies as ...
Breaking Biology Technology: